Event

Six months ago, the supplement industry was up in arms about the FDA’s New Dietary Ingredient final draft guidance. It could be a costly and crush innovation. It could crush small companies and stop large companies in their tracks. But on January 20, the picture changed. The Trump administration has come out against regulations and promised to cut budgets that could hamstring enforcement. NBJ Editor Rick Polito will lead a discussion on what the change in course means, with Larisa Pavlick, a former FDA investigator now working with the United Natural Products Alliance, supplements lawyer Ashish Talati and Scott Steinford, an industry veteran with a keen view on the historical perspective. Relevant New Hope Content Trades unite in opposition to FDA's NDI guidance document